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INTRODUCTION 1 
Overweight and obesity are considered important risk factors in the 2 
development of a series of cardiometabolic diseases [1], which largely remain 3 
asymptomatic during youth. These risks usually manifest themselves in 4 
adulthood yet may originate during infancy [2-4]. , as Higher levels of lipids and 5 
lipoproteins have been described in overweight or obese children and 6 
adolescents [5, 6], . Previous data from the Bogalusa study [4] have shown that 7 
elevations of concentrations of total cholesterol (TC), low-density lipoprotein 8 
cholesterol (LDL), and triglycerides, as well as and lower concentrations of high-9 
density lipoprotein cholesterol (HDL) in childhood, which have been significantly 10 
associated with later high prevalence (≈70%) of atherosclerotic lesions in young 11 
adulthood [4]. 12 
In addition to an unfavourable lipid profile [5], overweight and obese 13 
individuals usually also present impaired glucose metabolism [7] and higher 14 
levels of several inflammatory biomarkers [8] than their normal weight 15 
counterparts. Although C-reactive protein (CRP) has been the most used 16 
marker of inflammation, other biomarkers such as the acute phase reactants 17 
fibrinogen and complement factors C3 (C3) and C4 (C4), cytokines as 18 
interleukin-6 (IL-6), adipokines as leptin and adiponectin, and non-specific 19 
systemic markers of inflammation such as erythrocyte sedimentation rate (ESR) 20 
and white blood cells (WBC), have been explored as useful for assessing to 21 
assess risk of cardiovascular diseases, and to more accurately characterize the 22 
low-grade inflammatory profile of an individual [9-11], Further, these measures 23 
are valid in adults also valid in children and adolescents [12-16]. 24 
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The long-term maintenance of increased levels of some biomarkers in 25 
overweight and obese individuals reflect a state of chronic and systemic low-26 
grade inflammation, which seems to be a key component in the pathogenesis of 27 
insulin resistance, the best predictor of type 2 diabetes [10, 17], . Insulin 28 
resistance is the best predictor of diabetes, and which occurs several years 29 
before the onset of the disease [7], making early identification important for 30 
prevention and management of the disease. The homeostatic model 31 
assessment of insulin resistance (HOMA-IR) [18] is used as a valid measure of 32 
insulin resistance in non-diabetic children and adolescents [19], and has been 33 
reported as being substantially increased in overweight/obese children 34 
compared with normal-weight [20]. 35 
Birth weight (BW) is commonly used as a proxy measure of intrauterine 36 
development, and both low and high BW have been explored as determinants 37 
for impaired future health related-outcomes, such as type 2 diabetes and the 38 
metabolic syndrome later in life [18, 19]. However, others studies suggest that 39 
growth patterns in infancy and childhood might have a more pronounced effect 40 
than with BW per se [20, 21]. 41 
Since there is strong evidence that overweight and obesity tracks from 42 
early childhood to adolescence and adulthood [22], and that body mass index 43 
(BMI) is the most commonly used anthropometric index to define weight status 44 
in large samples [23, 24], its close monitoring throughout early life could 45 
represent not only a procedure to identify an overweight condition, but also an 46 
easy, but useful way to prevent and detect a series of health-related 47 
parameters/diseases associated with that condition, such as diabetes and 48 
cardiovascular diseases. 49 
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Although cross-sectional studies have consistently associated 50 
overweight with inflammatory and cardiometabolic biomarkers, to the best of our 51 
knowledge, those relations are not yet clear in the long-term. Further, it is not 52 
well established that if a persistently high BMI during infancy and childhood can 53 
predict an unfavourable state of biomarkers in adolescence. Thus, the main 54 
objective of this study was to assess the associations between early life 55 
anthropometric indicators such as birth weight or BMI at several time points of 56 
age (6,12 and 18 months, and at 2, 3, 4, 5 and 6 years), with indicators of 57 
inflammation, insulin resistance and lipid profile during in adolescence. 58 
 59 
 METHODS 60 
Study population, design and sampling 61 
This study is based on data from the Longitudinal Analysis of Biomarkers 62 
and Environmental Determinants of Physical Activity Study (LabMed Physical 63 
Activity Study), a 3-year longitudinal cohort study started during the fall of 2011, 64 
and carried out in five schools in the north of Portugal, with the main aim of 65 
assessing the independent and combined associations of dietary intake and 66 
fitness levels on blood pressure levels of adolescents. The study protocol and 67 
procedures are described in detail elsewhere [25]. Briefly, from an initial sample 68 
of 1229 apparently healthy adolescents (12–18 years old) that agreed to 69 
participate in that study, 534 provided blood samples. Subsequently, 5 70 
individuals were excluded due to high-sensitivity CRP values >10 mg/L, which 71 
were indicative of acute inflammation or illness [26]. Child Health Booklets 72 
records of 539 participants were also available for complete early life data 73 
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extraction. In total, 415 adolescents matched information from early life and 74 
blood variables, and, as such, composed the final sample for the present study. 75 
This study was conducted in accordance to the Helsinki Declaration for 76 
Human Studies of 1975, as revised in 2013 [27], and approved by the 77 
Portuguese Data Protection Authority (#1112434/2011) and the Portuguese 78 
Ministry of Science and Education (0246200001/2011). All participants were 79 
previously informed of this study aims, and written informed consent was 80 
obtained from participating adolescents and their parents/tutors.  81 
Early life data collection 82 
Information on birth and postnatal periods was retrospectively collected 83 
from individual child health booklets records provided by the participants, called 84 
Boletim de Saúde Infantil e Juvenil. Anthropometric data regarding weight, 85 
length and height measurements, available from birth up until the age of 6 86 
years, which were performed and recorded on the health booklets by the 87 
paediatricians during regular appointments with the participants, were extracted 88 
for the present analysis. Individuals were considered born with low BW 89 
(<2500g), adequate BW (2500–4000g), or high BW (>4000g), according WHO 90 
references [28]. BMI was calculated as weight divided by length squared 91 
(kg/m2) from birth up until the age of 2 years, and from 2 years onward 92 
calculated as usual (weight divided by squared height [kg/m2]). At the ages of 6, 93 
12 and 18 months, and at 2, 3, 4, 5 and 6 years, the participants were classified 94 
according the BMI-for-age percentiles sex specific references provided by the 95 
World health Organization [29, 30], in one of two possible categories: normal 96 
weight (including underweight individuals) or overweight (including obese 97 
participants). 98 
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 99 
Anthropometric measurements in adolescence 100 
Anthropometric measures such as weight and height were collected 101 
according standardized procedures [31] and described elsewhere [25]. BMI was 102 
then calculated as previously described (kg/m2), and all the adolescents were 103 
classified in two categories, normal weight (including underweight) or 104 
overweight (including obese), using the age and sex-specific BMI-for-age 105 
percentiles cut-off values proposed by the World Health Organization [30]. 106 
Pubertal stage assessment 107 
Pubertal stages of sexual maturation (A - breast development in girls; 108 
genital development in boys; and B – pubic hair development, for both sexes) 109 
were self-assessed by the participants according to the classification by Tanner 110 
[32], in a private place, and then communicated in a closed envelope to a 111 
researcher of the same sex, with stage 1 being pre-pubertal and 5 being adult 112 
maturation. Given the low number of participants at Tanner stage 1, these were 113 
integrated with Tanner stage 2 and formed the pre-/early pubertal group. 114 
Biochemical assessment 115 
Blood samples were collected by venepuncture from the antecubital vein 116 
from each participant early in the morning, following a 10-hour overnight fast.  117 
The samples were stored in sterile blood collection tubes in refrigerated 118 
conditions (4° to 8°C) for no longer than 4 hours, during the morning of 119 
collection, and then delivered to an analytical laboratory for testing for a series 120 
of inflammatory markers, lipid profile (total cholesterol and fractions, 121 
triglycerides), and glucose and insulin determinations, according to 122 
standardized procedures, as follows: (i) high-sensitivity CRP, latex enhanced 123 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
6
immunoturbidimetric assay (Siemens ADVIA 1800, Erlangen, Germany); (ii) 124 
fibrinogen, Clauss assay (Siemens BCS XP System, Erlangen, Germany); (iii) 125 
adiponectin and leptin, ELISA (Plate Reader); (iv) complement factor C3 and 126 
complement factor C4, PEG enhanced immunoturbidimetric assay (Siemens 127 
ADVIA 1800, Erlangen, Germany); (v) ESR, Westergren method (Starrsed, RR 128 
Mechanotronics, Netherlands); (vi) IL-6, Chemiluminescence immunoassay 129 
(Siemens Immulite 2000, Diagnostic Products Corporation, Los Angeles, CA); 130 
(vii) WBC, Cytometry (Siemens Advia 2120i); (viii) Glucose, Hexokinase method 131 
(Siemens Advia 1600/1800 Erlangen, Germany); (ix) Insulin, 132 
Chemiluminescence immunoassay (Siemens ACS Centaur System, Erlangen, 133 
Germany); (x) TC, HDL, LDL and triglycerides were measured by standard 134 
enzymatic methods (Siemens Advia 1600/1800, Erlangen, Germany). CRP, C3, 135 
C4, IL-6, adiponectin, leptin, glucose, insulin, TC, HDL, LDL and triglycerides 136 
were determined in serum, ESR and WBC were determined in whole blood, and 137 
fibrinogen was determined in plasma.  138 
The homeostatic model assessment of insulin resistance (HOMA-IR) [as 139 
the product of fasting insulin (µlU/ml) and fasting glucose (mmol/l) divided by 140 
the constant 22.5] [33] was used as a surrogate measure of insulin resistance, 141 
and has been used as a valid measure in non-diabetic children and adolescents 142 
[34], reported as being substantially increased in overweight/obese children 143 
compared with normal-weight [35]. The ratio of TC to HDL (TC/HDL) was 144 
calculated, and used in the analyses as an index of an atherogenic lipid profile, 145 
as some studies have suggested that it provides a useful summary of the joint 146 
contribution of TC and HDL to cardiovascular disease risk [36-38]. 147 
Socioeconomic Status 148 
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The Family Affluence Scale [39] was used as a proxy measure of 149 
adolescent's socioeconomic status. This scale is a four-item questionnaire 150 
regarding information on vehicles, home, lifestyle and access to technology, 151 
with a range of scores from 0 to 9 points, that allows adolescents to indirectly 152 
report their family income, with the highest score corresponding to the highest 153 
socioeconomic level. 154 
KIDMED index 155 
The KIDMED index [40] (Mediterranean Diet Quality Index for children 156 
and adolescents) was used to assess the degree of adherence to the 157 
Mediterranean diet, considered a healthy dietary model and associated to a 158 
lower occurrence of cardiometabolic diseases [41] and certain cancer types 159 
[42]. This index is based on a 16 questions self-administered, which sustain 160 
principles of Mediterranean dietary patterns as well as those that undermine it. 161 
Questions indicating a negative connotation with respect to the Mediterranean 162 
diet were assigned a value of -1 and those with a positive aspect +1. The sum 163 
of the values ranges from 0 to 12, where a higher index means good adherence 164 
to the Mediterranean diet. 165 
Statistical analyses 166 
Descriptive statistics are presented as means and standard deviations. 167 
Two-sided Student’s t-test was used to compare groups for continuous 168 
variables. 169 
As no marker alone seems to perfectly characterize the inflammatory 170 
profile of an individual, several studies in paediatric populations have been 171 
using a combined score of inflammatory biomarkers, since this approach seems 172 
to provide a more comprehensive assessment and characterization of the 173 
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inflammatory state in adolescence [10, 12]. For that purpose, partial correlations 174 
adjusted for age, sex, pubertal stage, BMI, BF%, adherence to a Mediterranean 175 
dietary pattern (KIDMED index) and socioeconomic status, were used as a 176 
preliminary analysis to examine the associations between each inflammatory 177 
biomarker with BW and BMI at each age point during childhood (Supplemental 178 
Table 1). Significant correlations (p≤0.05) served as the criteria used to select 6 179 
inflammatory biomarkers (C3, C4, CRP, ESR, fibrinogen, leptin) for the 180 
construction of a continuous inflammatory score. For each biomarker, a z-score 181 
was computed by sex, age and pubertal status, and all the z-scores of the 182 
individual factors were then summed to create a cluster of inflammatory 183 
biomarkers. A higher score is indicative of a worse inflammatory profile. 184 
Linear regression analyses adjusted for age, pubertal stage, BMI, BF%, 185 
socioeconomic status and KIDMED index were performed to determine the 186 
associations between the clustered inflammatory biomarkers score, HOMA-IR 187 
and TC/HDL (as dependent variables), with BW and BMI at the ages of 6, 12 188 
and 18 months, and at 2, 3, 4, 5 and 6 years of age (as predictor variables). 189 
Unstandardized regression coefficients were used to express the beta in the 190 
linear regression analyses, and the coefficient of determination was used to 191 
assess the variance explained in the model. 192 
Analysis of Covariance with Bonferroni post-hoc multiple comparison 193 
tests were used to assess if children that were normal weight and 194 
overweight/obese at each time point of age analysed, presented differences in 195 
inflammatory, insulin resistance and lipid profiles during adolescence. 196 
Covariates included were age, pubertal stage, BMI, BF%, socioeconomic status 197 
and KIDMED index. 198 
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Replication of all the analyses was performed without preterm deliveries 199 
(n=30, 7.2%) and twins (n=8, 1.9%), in order to reduce bias. However, as these 200 
analyses did not yield different results, we included all the 415 participants in 201 
the final analyses. 202 
Data were analysed using the Statistical Package for Social Sciences 203 
version 24.0 (SPSS, IBM Corp., NY, USA). A p-value of ≤0.05 was considered 204 
to denote statistical significance. 205 
 206 
RESULTS 207 
Tables 1 and 2 presents the descriptive characteristics of the participants 208 
at early life and adolescence periods. Boys were taller and heavier than girls, 209 
and presented significantly higher values of BW, birth length, and BMI at 6, 12 210 
and 18 months of age (p≤0.05 for all). BF%, adiponectin, ESR, fibrinogen, 211 
leptin, insulin, HOMA-IR, TC, LDL, triglycerides and HDL values were 212 
significantly higher in girls, while fasting glucose and TC/HDL were significantly 213 
higher in boys (p≤0.05 for all). 214 
 215 
 216 
 217 
 218 
 219 
 220 
 221 
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 222 
 223 
 224 
 225 
Table 1. Characteristics of the Participants at Early Life and Adolescence Periods 226 
 All (n = 415) Girls (n = 220) Boys (n = 195) 
Variables Mean (SD) Mean (SD) Mean (SD) 
Age (years) 14.1 (1.6) 14.1 (1.7) 14.0 (1.6) 
Height (cm) 159.2 (9.2) 157.4 (6.7) 161.4 (10.9) ** 
Weight (kg) 54.5 (12.7) 52.9 (10.9) 56.3 (14.3) * 
BMI (kg/m2) 21.3 (3.8) 21.3 (3.9) 21.3 (3.8) 
NW (n; %) 278; 67% 156; 70.9% 122; 62.6% 
OW (n; %) 137; 33% 64; 29.1% 73; 37.4% 
BF (%) 21.1 (8.0) 25.3 (6.9) 16.5 (6.5) ** 
Birth weight (g) 3 277 (492) 3 190 (490) 3 377 (476) ** 
Low (n; %) 27; 6.5% 19; 8.6% 8; 4.1% 
Normal (n; %) 366; 88.2% 192; 87.3% 174; 89.2% 
High (n; %) 22; 5.3% 9; 4.1% 13; 6.7% 
Birth length (cm) 49.1 (2.2) 48.6 (2.2) 49.7 (2.0) ** 
BMI at 6 months (kg/m2) 17.4 (1.5) 17.1 (1.4) 17.8 (1.6) ** 
BMI at 12 months (kg/m2) 17.7 (1.5) 17.4 (1.4) 18.1 (1.6) ** 
BMI at 18 months (kg/m2) 17.2 (1.4) 17.0 (1.4) 17.5 (1.5) * 
BMI at 2 years (kg/m2) 16.8 (1.5) 16.7 (1.4) 17.0 (1.6) 
BMI at 3 years (kg/m2) 16.6 (1.7) 16.4 (1.8) 16.7 (1.6) 
BMI at 4 years (kg/m2) 16.6 (1.9) 16.5 (1.9) 16.7 (1.9) 
BMI at 5 years (kg/m2) 16.9 (2.2) 16.8 (2.3) 16.9 (2.2) 
BMI at 6 years (kg/m2) 17.2 (2.6) 17.0 (2.5) 17.5 (2.7) 
Pubertal stage A (%)    
 Stage ≤ II 8.4 3.6 13.8 
 Stage III 34.2 31.4 37.4 
 Stage IV 43.9 52.3 34.4 
 Stage V 13.5 12.7 14.4 
Pubertal stage B (%)    
 Stage ≤ II 7.7 2.7 13.3 
 Stage III 23.9 25.5 22.1 
 Stage IV 46.7 44.1 49.7 
 Stage V 21.7 27.7 14.9 
 KIDMED index 7.2 (2.1) 7.3 (2.0) 7.0 (2.1) 
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 Socioeconomic status (FAS) 6.5 (1.7) 6.6 (1.7) 6.4 (1.7) 
∗p < 0.05; ∗∗p < 0.001 for sex comparisons (two-tailed t-tests for continuous variables or chi-square for categorical 227 
variables). 228 
Abbreviations: BF (%), body fat percentage; BMI, body mass index; FAS, family affluence scale; NW, underweight + 229 
normal weight; OW, overweight + obese; SD, standard deviation; Pubertal stages of sexual maturation (A - breast 230 
development in girls; genital development in boys; and B – pubic hair development, for both sexes);  231 
 232 
 233 
 234 
 235 
Table 2. Biochemical Characteristics of the Adolescents 236 
 All (n = 415) Girls  (n = 220) Boys (n = 195) 
Variables Mean (SD) Mean (SD) Mean (SD) 
Adiponectin (mg/L) 12.0 (5.6) 13.2 (6.0) 10.7 (4.7) ** 
 
C-reactive protein (mg/L) 0.9 (1.7) 0.7 (1.6) 1.0 (1.8) 
Complement C3 (mg/dL) 118.4 (16.1) 118.7 (16.2) 118.0 (16.1) 
 Complement C4 (mg/dL) 21.1 (6.4) 21.4 (6.6) 20.9 (6.2) 
 Erythrocyte sedimentation rate 
(mm/h) 6.5 (6.6) 7.6 (6.9) 5.3 (6.0) ** 
 Fibrinogen (mg/dL) 265.4 (43.3) 269.5 (43.1) 260.8 (43.2) * 
 IL-6 (ng/L) 3.8 (4.8)  3.7 (4.3) 3.8 (5.3) 
 Leptin (ng/ml) 4.3 (5.0) 6.2 (5.6) 2.1 (3.1) ** 
 White blood cells (109/L) 7.1 (1.7) 7.3 (1.6) 7.0 (1.7) 
 Fasting glucose (mmol/L) 4.9 (0.4) 4.8 (0.4) 5.0 (0.4) * 
 Insulin (µU/ml) 14.8 (7.56) 16.04 (7.42) 13.4 (7.5) ** 
 HOMA-IR 3.3 (1.8) 3.5 (1.8) 3.0 (1.7) * 
 Total cholesterol (mg/dL) 154.1 (28.1) 159.4 (28.6) 148.3 (26.4) ** 
 LDL (mg/dL) 85.1 (23.6) 87.8 (24.3) 82.1 (22.5) * 
 HDL (mg/dL) 54.9 (12.1) 57.9 (12.3) 51.5 (10.8) ** 
 Triglycerides (mg/dL) 67.9 (32.2) 70.9 (32.6) 64.6 (31.5) * 
 TC/HDL ratio (mg/dL) 2.9 (0.6) 2.8 (0.6) 3.0 (0.6) * 
∗p ≤ 0.05; ∗∗p < 0.001 for sex comparisons (two-tailed t-test) 237 
Abbreviations: HOMA-IR, Homeostatic model assessment of insulin resistance index; IL-6, Interleukin 6; HDL, high-238 
density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; SD, standard deviation; TC/HDL ratio, total 239 
cholesterol/high-density lipoprotein cholesterol ratio 240 
 241 
 242 
Regression analyses in Tables 3 and 4 showed that, for both sexes, from 243 
the age of 2 years onwards BMI was significantly and positively associated with 244 
the inflammatory score and HOMA-IR in adolescence, after adjustments for 245 
age, pubertal stage, BMI, BF%, socioeconomic status and KIDMED index. 246 
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TC/HDL ratio at adolescence was also positively associated with BMI, but only 247 
at the ages of 5 and 6 years. BMI in adolescence remained positively 248 
associated with the inflammatory score, HOMA-IR and TC/HDL. 249 
 250 
 251 
 252 
 253 
Table 3. Linear Regression Coefficients, Significance Values and Coefficients of Determination, 254 
Examining the Associations Between Birth Weight and BMI at Several Time Points of Age, and 255 
Inflammatory Score, HOMA-IR and TC/HDL Ratio of Adolescent Girls, Adjusted for Age, 256 
Pubertal Stage, BMI, BF%, Socioeconomic Status and KIDMED Index 257 
 Dependent Variables  
 Inflammatory Score HOMA–IR TC/HDL 
Birth weight 
B (p value) 0.00 (0.71) 0.00 (0.10) -4.90 (0.95) 
r2 
-0.00 0.10 0.05 
BMI at 6 months 
B (p value) 0.51 (0.28) 0.09 (0.35) -0.02 (0.58) 
r2 0.03 0.07 0.06 
BMI at 12 months 
B (p value) 0.51 (0.48) 0.09 (0.42) -0.01 (0.71) 
r2 0.02 0.08 0.00 
BMI at 18 months 
B (p value) 0.56 (0.15) 0.14 (0.12) -0.01 (0.78) 
r2 0.02 0.09 0.05 
BMI at 2 years 
B (p value) 0.82 (<0.01) 0.21 (0.02) 0.05 (0.12) 
r2 0.06 0.12 0.02 
BMI at 3 years 
B (p value) 0.79 (<0.01) 0.23 (<0.01) 0.07 (0.09) 
r2 0.09 0.18 0.07 
BMI at 4 years 
B (p value) 0.93 (<0.01) 0.21 (<0.01) 0.03 (0.34) 
r2 0.15 0.16 0.00 
BMI at 5 years 
B (p value) 0.92 (<0.01) 0.35 (<0.01) 0.07 (<0.01) 
r2 0.22 0.23 0.13 
BMI at 6 years 
B (p value) 0.77 (<0.01) 0.17 (<0.01) 0.04 (0.03) 
r2 0.19 0.14 0.06 
Current BMI 
B (p value) 0.51 (<0.01) 0.15 (<0.01) 0.04 (<0.01) 
r2 0.22 0.15 0.11 
Abbreviations: BMI, body mass index; B, linear regression coefficient; p, significance value; r2, coefficient of 258 
determination; HOMA–IR, homeostatic model assessment of insulin resistance index; TC/HDL, total cholesterol to high-259 
density lipoprotein cholesterol ratio. 260 
 261 
 262 
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 263 
 264 
 265 
 266 
 267 
 268 
Table 4. Linear Regression Coefficients, Significance Values and Coefficients of Determination, 269 
Examining the Associations Between Birth Weight and BMI at Several Time Points of Age, and 270 
Inflammatory Score, HOMA-IR and TC/HDL Ratio of adolescent boys, Adjusted for Age, 271 
Pubertal Stage, BMI, BF%, Socioeconomic Status and KIDMED Index 272 
 Dependent Variables  
 Inflammatory Score HOMA–IR TC/HDL 
Birth weight 
B (p value) 1.37 (0.98) -3.73 (0.89) -6.87 (0.47) 
r2 0.00 0.01 0.00 
BMI at 6 months 
B (p value) 
-0.19 (0.36) 0.02 (0.82) 0.02 (0.45) 
r2 0.06 0.03 0.01 
BMI at 12 months 
B (p value) 
-0.01 (0.96) 0.09 (0.44) 0.02 (0.58) 
r2 0.12 0.02 0.02 
BMI at 18 months 
B (p value) 
-0.02 (0.95) 0.19 (0.05) -0.01 (0.78) 
r2 0.06 0.03 0.00 
BMI at 2 years 
B (p value) 0.04 (0.01) 0.16 (0.02) 0.03 (0.31) 
r2 0.03 0.07 0.02 
BMI at 3 years 
B (p value) 0.15 (<0.05) 0.20 (0.03) 0.03 (0.38) 
r2 0.05 0.04 0.14 
BMI at 4 years 
B (p value) 0.33 (<0.01) 0.27 (<0.01) 0.05 (0.10) 
r2 0.11 0.07 0.03 
BMI at 5 years 
B (p value) 0.29 (<0.01) 0.23 (<0.01) 0.04 (<0.01) 
r2 0.11 0.08 0.03 
BMI at 6 years 
B (p value) 0.36 (0.02) 0.32 (<0.01) 0.05 (<0.01) 
r2 0.10 0.25 0.03 
Current BMI 
B (p value) 0.44 (<0.01) 0.23 (<0.01) 0.04 (<0.01) 
r2 0.17 0.24 0.07 
Abbreviations: BMI, body mass index; B, linear regression coefficient; p, significance value; r2, coefficient of 273 
determination; HOMA–IR, homeostatic model assessment of insulin resistance index; TC/HDL, total cholesterol to high-274 
density lipoprotein cholesterol ratio. 275 
 276 
ANCOVA adjusted for age, pubertal stage, BMI, BF%, socioeconomic 277 
status and KIDMED index confirmed the results of the linear regressions, as 278 
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can be seen in Tables 5 and 6. When compared to normal weight, overweight 279 
children at the ages of 2, 3, 4, 5, and 6 years, presented a significantly higher 280 
inflammatory score and HOMA-IR later in adolescence (p ≤ 0.05). From the age 281 
of 5, those who were overweight also presented a higher TC/HDL ratio. In 282 
adolescence, obese individuals also had higher inflammatory score, HOMA-IR 283 
and TC/HDL ratio than their normal weight counterparts. 284 
 285 
Table 5. Analyses of Covariance of Values of the Inflammatory Score, HOMA-IR and TC/HDL 286 
Ratio of Adolescent Girls, Accordingly Their Birth Weight Category and BMI Status at Several 287 
Time Points of Age, Adjusted for Age, Pubertal Stage, BMI, BF%, Socioeconomic Status and 288 
KIDMED Index 289 
 
 Inflammatory Score HOMA–IR TC/HDL 
 
 Mean (SE) Mean (SE) Mean (SE) 
Birth weight 
LOW (8.6%) -0.49 (0.97) 
 
3.53 (0.39)  2.82 (0.13)  
NORMAL (87.3%) 0.11 (0.31) 3.46 (0.12)  2.84 (0.04)  
HIGH (4.1%) -1.28 (1.43) 4.53 (0.57)  2.73 (0.19)  
BMI at 6 months 
NW (85.4%) -0.15 (0.34) 
 
3.41 (0.14)  2.82 (0.04)  
OW (14.6%) 0.86 (0.83) 3.78 (0.34)  2.81 (0.11)  
BMI at 12 months 
NW (68.7%) -0.19 (0.44) 
 
3.69 (0.20)  2.83 (0.06)  
OW (31.3%) 0.42 (0.65) 3.63 (0.29)  2.77 (0.09)  
BMI at 18 months 
NW (61.1%) -0.32 (0.40) 
 
3.34 (0.16)  2.82 (0.06)  
OW (38.9%) 0.50 (0.50) 3.78 (0.20)  2.80 (0.07)  
BMI at 2 years 
NW (55.9%) -0.85 (0.44) 
** 
3.20 (0.16) 
* 
2.73 (0.06)  
OW (44.1%) 1.06 (0.49) 3.78 (0.18) 2.89 (0.07)  
BMI at 3 years 
NW (63.0%) -0.81 (0.41) 
** 
3.14 (0.16) 
** 
2.78 (0.06)  
OW (37.0%) 1.39 (0.54) 3.92 (0.21) 2.92 (0.07)  
BMI at 4 years 
NW (63.6%) -1.05 (0.43) 
*** 
3.39 (0.18) 
* 
2.80 (0.06)  
OW (36.4%) 1.87 (0.58) 4.03 (0.24) 2.90 (0.08)  
BMI at 5 years 
NW (61.8%) -1.12 (0.46) 
*** 
3.25 (0.20) 
*** 
2.72 (0.06) 
** 
OW (38.2%) 1.79 (0.58) 4.41 (0.25) 3.06 (0.08) 
BMI at 6 years 
NW (56.4%) -1.17 (0.48) 
*** 
3.30 (0.20) 
* 
2.74 (0.06) 
* 
OW (43.6%) 1.49 (0.54) 3.93 (0.23) 2.93 (0.07) 
Current BMI  
NW (71.5%) -1.05 (0.28) 
*** 
3.19 (0.12) 
*** 
2.77 (0.04) 
** 
OW (28.5%) 2.63 (0.45) 4.34 (0.20) 3.01 (0.07) 
∗p ≤ 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 290 
Abbreviations: BMI, body mass index; HOMA–IR, homeostatic model assessment of insulin resistance index; TC/HDL, 291 
total cholesterol to high-density lipoprotein cholesterol ratio. NW, normal weight; OW, overweight; SEM, standard error 292 
of the mean. 293 
 294 
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 302 
Table 6. Analyses of Covariance of Values of the Inflammatory Score, HOMA-IR and TC/HDL 303 
Ratio of Adolescent Boys, Accordingly Their Birth Weight Category and BMI Status at Several 304 
Time Points of Age, Adjusted for Age, Pubertal Stage, BMI, BF%, Socioeconomic Status and 305 
KIDMED Index 306 
 
 Inflammatory Score HOMA–IR TC/HDL 
 
 Mean (SE) Mean (SE) Mean (SE) 
Birth weight 
LOW (4.1%) -0.28 (0.82) 
 
3.30 (0.33)  2.91 (0.12)  
NORMAL (89.2%) 0.10 (0.22) 3.25 (0.09)  2.90 (0.03)  
HIGH (6.7%) -1.37 (0.91) 3.36 (0.37)  2.73 (0.13)  
BMI at 6 months 
NW (75.3%) -0.04 (0.26) 
 
3.20 (0.11)  2.87 (0.04)  
OW (24.7%) 0.17 (0.54) 3.56 (0.23)  2.94 (0.08)  
BMI at 12 months 
NW (54.9%) -0.12 (0.33) 
 
3.28 (0.15)  2.88 (0.05)  
OW (45.1%) 0.20 (0.43) 3.50 (0.19)  2.93 (0.06)  
BMI at 18 months 
NW (55.8%) -0.11 (0.30) 
 
3.13 (0.12)  2.90 (0.04)  
OW (44.2%) 0.16 (0.35) 3.48 (0.15)  2.87 (0.05)  
BMI at 2 years 
NW (58.8%) -0.57 (0.32) 
** 
3.03 (0.12) 
* 
2.85 (0.05)  
OW (41.2%) 0.76 (0.36) 3.47 (0.14) 2.93 (0.05)  
BMI at 3 years 
NW (64.4%) -0.46 (0.30) 
* 
2.96 (0.12) 
** 
2.87 (0.04)  
OW (35.6%) 0.81 (0.40) 3.63 (0.16) 2.98 (0.06)  
BMI at 4 years 
NW (60.5%) -0.65 (0.31) 
** 
3.02 (0.14) 
** 
2.89 (0.05)  
OW (39.5%) 1.07 (0.41) 3.81 (0.18) 2.97 (0.06)  
BMI at 5 years 
NW (54.4%) -0.82 (0.34) 
*** 
2.91 (0.14) 
*** 
2.83 (0.05) 
* 
OW (45.6%) 1.15 (0.40) 3.86 (0.17) 3.00 (0.06) 
BMI at 6 years 
NW (45.0%) -0.96 (0.38) 
*** 
2.94 (0.15) 
*** 
2.85 (0.05) 
* 
OW (55.0%) 1.00 (0.38) 3.75 (0.16) 3.02 (0.06) 
Current BMI  
NW (67.6%) -1.08 (0.20) 
*** 
2.86 (0.09) 
*** 
2.81 (0.03) 
*** 
OW (32.4%) 2.48 (0.31) 4.09 (0.13) 3.08 (0.05) 
∗p ≤ 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 307 
Abbreviations: BMI, body mass index; HOMA–IR, homeostatic model assessment of insulin resistance index; TC/HDL, 308 
total cholesterol to high-density lipoprotein cholesterol ratio. NW, normal weight; OW, overweight; SEM, standard error 309 
of the mean. 310 
 311 
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Our study has three main findings: (i) BW showed no associations with 314 
any of the cardiometabolic outcomes in adolescence, and there were no 315 
differences in those outcomes regardless of BW; (ii) The main findings of this 316 
study showed that from 2 years onwards, overweight was positively associated 317 
with higher inflammatory scores and HOMA-IR in adolescence, ; (iii) and that 318 
positive associations between BMI and TC/HDL became statistically significant 319 
from the age of 5 years. 320 
Regardless of BW status, we observed no differences in the levels of 321 
inflammatory scores, insulin resistance or unfavourable lipid profiles later in 322 
adolescence. Our results are in agreement agree with other reports [43-45], 323 
suggesting that BW is not as relevant as other anthropometric measures during 324 
childhood in the prediction of future cardiometabolic outcomes, and with 325 
previous studies with children and adolescents that have also reported no 326 
associations between BW and several inflammatory biomarkers [45-49]. 327 
However, the relatively small number of participants in the low BW category (27 328 
participants) and in the high BW category (22 participants) advises some 329 
caution in inferring solid conclusions about these associations. For example, 330 
Labayen et al. [15] found mixed results, reporting associations between BW and 331 
some biomarkers such as (C3, C4 and fibrinogen), but not with CRP, as well as 332 
other studies suggesting that, at least low BW, may be associated with 333 
increased systemic inflammation during adolescence [50] and adulthood [51]. 334 
Instead of an individualized analysis of each biomarker, we used an 335 
inflammatory score, as it provided a more comprehensive characterization of 336 
the inflammatory state in adolescence [10, 12]. In addition to low-grade 337 
inflammation, our data concurs with other studies that have reported no 338 
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associations between BW and other health-related outcomes, such as insulin 339 
resistance or blood lipids in late childhood [44, 52] and adolescence [49, 53]. 340 
As suggested by Jeffery et al. [44], demographic changes may be one of 341 
the reasons for the apparent decrease in the importance of BW in the 342 
development of later cardiometabolic diseases [21]. It must be taken into 343 
account considered that the concept of foetal programming, and its 344 
pathophysiologic consequences later in life, emerged from the pioneer works of 345 
Barker et al. [54] and Hales et al. [55], which were conducted on populations 346 
born in the early 20th century, who were born and grew up in the pre–World War 347 
II period, but matured in another. Moreover, socioeconomic and health 348 
conditions were totally different from those of today. 349 
According to World Health Organization reference values [28], 6.5% of 350 
the participants in this study had low BW (<2500g) and 5.3% high BW 351 
(>4000g). However, when the same participants were assessed during the 352 
adolescence period, one third of the sample was classified as being overweight 353 
or obese. This seems to support the need for a greater emphasis that should be 354 
given on the monitoring of BMI status and its development during infancy and 355 
childhood, even more so because overweight and obesity appear to track 356 
throughout life from early ages [22, 56]. In addition, it seems that the longer an 357 
individual is overweight during adolescence and adulthood, the more adverse 358 
their level of adipokines and inflammatory markers will be later in life [57].  359 
Skinner et al. [58] showed that multiple inflammatory markers are 360 
strongly and positively associated with increasing weight status in children as 361 
young as age 3. Although in the present study we did not have inflammatory 362 
biomarkers data at those early ages, we observed that being overweight from 363 
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the age of 2 years onwards was consistently associated with an unfavourable 364 
inflammatory score and insulin resistance during adolescence. Other studies 365 
have shown that rapid weight gain throughout life (particularly after 2 years of 366 
age) was positively related with increased leptin concentrations during 367 
childhood [59], and with increased leptin and CRP levels in young adulthood in 368 
males and females [60]. We are not aware of other studies that have measured 369 
cardiometabolic outcomes during adolescence using BMI at various time points 370 
of age as predictor variable, as we did in the present study. 371 
In a 9–year longitudinal study with children, Gardner et al. [43] reported 372 
that weight alone at 5 years of age presented little relation to BW, but closely 373 
predicted weight at 9 years of age. In addition, the authors composed a 374 
metabolic score based on insulin resistance, blood pressure, triglycerides, and 375 
TC/HDL ratio, and found that it was also poorly predicted by BW, but was 376 
associated with weight at 5 years, and even more at 9 years. Our results 377 
showed that children who were overweight from the age of 5 presented a higher 378 
TC/HDL ratio in adolescence. Another study [61] have also reported that the 379 
time period at around 5 years of age was a critical period for the development of 380 
overweight and obesity, as well as obesity-related factors, supporting the 381 
suggestion that a single measure of weight at 5 years of age could provide an 382 
indicator to future health for the individual [43]. 383 
Our data shows that, during adolescence, BMI maintained a positive 384 
association with inflammatory score, HOMA-IR and TC/HDL ratio. Given that 385 
the pro-inflammatory state seems to track from adolescence to adulthood [62], 386 
the findings of this report seem to be of interest, because they support and 387 
emphasize the potential value of an early screening for unhealthy BMI. A timely 388 
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intervention for its improvement during growth may represent an early factor for 389 
the acquisition and maintenance of a healthy cardiometabolic profile in later 390 
ages [2, 20]. 391 
Our study is not without limitations. First, from the age of 6 years 392 
onwards, the routine appointments to the paediatrician become more irregular 393 
than in the first years of life, and consequently, anthropometric records were 394 
sparse, and due to the loss of data it was impossible to run analyses for later 395 
ages. Second, we have no information about the pregnancy, and the evolution 396 
of the pregnant (weight gain, maternal BMI, risk factors, e.g. smoking). 397 
However, we have information on the duration of the pregnancy, which allowed 398 
us to identify pre- or post-term babies.  Last, the use of a single measure of 399 
each inflammatory biomarker may eventually not reflect a long-term pattern of 400 
that specific biomarker. Nevertheless, to somewhat overcome this limitation, we 401 
have analyzed several inflammatory biomarkers, which provided us with better 402 
global picture of the inflammatory status of the adolescents, and this constitutes 403 
one of the strengths of this study. Another strong point of this report is the direct 404 
extraction from the written records of data relative to birth and growth until the 405 
age of 6 years old, as we did not rely on parent reports. 406 
In conclusion, our results suggest that the maintenance of a high BMI 407 
from very early ages was consistently associated with worse inflammatory and 408 
lipid profiles, and increased insulin resistance in adolescence. On the other 409 
hand, no associations were found between BW and the same analysed 410 
outcomes.  411 
 412 
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Supplemental Table 1. Partial correlations adjusted for sex, age and pubertal stage between birth weight or BMI at 629 
several ages, and birth weight and inflammatory biomarkers. 630 
 BW CRP FIBRIN ESR C3 C4 LEPTIN ADIPO IL-6 WBC 
Birth weight  - -0.05 -0.05 0.02 -0.07 -0.03 0.02 0.03 -0.06 -0.1 
Birth length  0,74*** -0.02 -0.05 0.00 -0.06 0.01 0.01 -0.02 -0.05 -0.08 
BMI at 6 months  0,11 -0.02 0.03 0.00 0.01 -0.04 0.15 0.11 -0.02 -0.08 
BMI at 12 months  0,03 -0.06 0.07 0.05 0.08 -0.02 0.09 0.08 -0.02 -0.00 
BMI at 18 months  0,12 -0.01 0.05 0.04 0.05 0.03 0.19*** 0.06 -0.05 -0.06 
BMI at 2 years  0,04 -0.01 0.09 0.14* 0.12* 0.09 0.17** 0.06 0.00 -0.03 
BMI at 3 years  -0,02 0.08 0.11* 0.12* 0.15** 0.06 0.32*** -0.03 -0.11 -0.02 
BMI at 4 years  -0.04 0.06 0.17** 0.11 0.14* 0.12* 0.44*** -0.04 -0.05 -0.06 
BMI at 5 years  -0,09 0.12 0.22*** 0.12* 0.23*** 0.17** 0.49*** -0.01 -0.09 -0.05 
BMI at 6 years  -0.07 0.18 ** 0.22** 0.13* 0.29*** 0.17** 0.53*** -0.09 -0.06 0.05 
Current BMI  0,06 0.19 *** 0.26*** 0.13** 0.39*** 0.20*** 0.62*** -0.18 0,05 0,09 
∗p ≤ 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 631 
Abbreviations: BMI, body mass index; BW, birth weight; CRP, C-reactive protein; FIBRIN, fibrinogen; ESR, erythrocyte sedimentation 632 
rate; C3, complement C3; C4, complement C4; ADIPO, adiponectin; IL-6, interleukin 6; WBC, white blood cells. 633 
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Highlights: 
 
 
1. Birth weight show no associations with any cardiometabolic outcome in 
adolescence; 
 
2. Overweight at 2 years was associated with inflammation and HOMA-IR in 
adolescence; 
 
3. Overweight at 5 years was associated with worse lipid profiles in adolescence; 
 
4. A persistently high BMI during infancy and childhood is associated with an 
unfavourable state of biomarkers in adolescence; 
